NCT03430479View on ClinicalTrials.gov

Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 22, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

April 1, 2021

Conditions
Breast Cancer
Interventions
DRUG

Cohort A

Radiation + Nivolumab + hormone therapy

Trial Locations (1)

606-8507

Kyoto University Hospital, Kyoto

All Listed Sponsors
lead

Kyoto Breast Cancer Research Network

OTHER

NCT03430479 - Anti PD-1 Antibody With Radiation Therapy in Patients With HER2-negative Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter